ID
15346
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (4)
- 8/13/15 8/13/15 - Martin Dugas
- 5/23/16 5/23/16 -
- 5/24/16 5/24/16 -
- 5/28/16 5/28/16 -
Uploaded on
May 28, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Treatment deferral Multiple Sclerosis ALAIN01 NCT02419378
Treatment deferral Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Similar models
Treatment deferral Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
C0205421 (UMLS CUI-2)
C0006147 (UMLS CUI [1,2])
C2698600 (UMLS CUI [2])
C2698589 (UMLS CUI [3])